RMAM
TEVA icon

Raab & Moskowitz Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$123K – 138
2020
Q2 		$123K Hold
10,000
– – 0.06% 133
2020
Q1 		$89K Buy
+10,000
New +$102K 0.05% 134
2015
Q1 		– Sell
-1,469
Closed -$84K – 335
2014
Q4 		$84K Buy
+1,469
New +$81.8K 0.05% 154

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Raab & Moskowitz Asset Management's TEVA Position: Q3 2020 in Review

Raab & Moskowitz Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2020, closing a stake of 10,000 shares — an estimated $123K sold.

Raab & Moskowitz Asset Management first reported a position in TEVA in Q4 2014 and held it in 3 quarters. The position peaked at $123K in Q2 2020. 443 funds tracked by Wall St. Rank hold TEVA as of Q3 2020.

  • Raab & Moskowitz Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Raab & Moskowitz Asset Management sold 10,000 Teva Pharmaceuticals shares in Q3 2020, an estimated $123K.
  • Raab & Moskowitz Asset Management first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Raab & Moskowitz Asset Management's Teva Pharmaceuticals position peaked at $123K in Q2 2020.
  • 443 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.